These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15597802)

  • 21. Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis.
    Gomes RN; Bozza FA; Amâncio RT; Japiassú AM; Vianna RC; Larangeira AP; Gouvêa JM; Bastos MS; Zimmerman GA; Stafforini DM; Prescott SM; Bozza PT; Castro-Faria-Neto HC
    Shock; 2006 Jul; 26(1):41-9. PubMed ID: 16783197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.
    Castillo L; Carcillo J
    Pediatr Crit Care Med; 2009 May; 10(3):387-92. PubMed ID: 19325510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of sepsis: what changed during the last decades?
    Reinhart K; Karzai W
    Acta Anaesthesiol Scand Suppl; 1997; 111():174-6. PubMed ID: 9421001
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anti-inflammatory therapy in sepsis].
    Briegel J; Weis F; Kilger E
    Chirurg; 2003 Jun; 74(6):590-1; author reply 591-2. PubMed ID: 12916500
    [No Abstract]   [Full Text] [Related]  

  • 25. [Role of ketamine in sepsis and systemic inflammatory response syndrome].
    Lange M; Bröking K; van Aken H; Hucklenbruch C; Bone HG; Westphal M
    Anaesthesist; 2006 Aug; 55(8):883-91. PubMed ID: 16775727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate immunity in sepsis pathogenesis and its modulation: new immunomodulatory targets revealed.
    Kumar V; Sharma A
    J Chemother; 2008 Dec; 20(6):672-83. PubMed ID: 19129063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-inflammatory mechanisms of sepsis.
    Shubin NJ; Monaghan SF; Ayala A
    Contrib Microbiol; 2011; 17():108-124. PubMed ID: 21659749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A promising anti-inflammatory and anti-thrombotic drug for sepsis treatment.
    Im DS
    Arch Pharm Res; 2011 Mar; 34(3):339-42. PubMed ID: 21547664
    [No Abstract]   [Full Text] [Related]  

  • 29. N-acetylcysteine for sepsis and systemic inflammatory response in adults.
    Visvanathan V
    Crit Care Nurse; 2013 Aug; 33(4):76-7. PubMed ID: 23908173
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-inflammatory treatment of acute and chronic pneumonia.
    Skerrett SJ; Park DR
    Semin Respir Infect; 2001 Mar; 16(1):76-84. PubMed ID: 11309715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of anticoagulation proteins in the management of systemic inflammatory response associated with sepsis.
    Erez O
    Thromb Res; 2013 Apr; 131(4):293-4. PubMed ID: 23399442
    [No Abstract]   [Full Text] [Related]  

  • 32. Sepsis and mediator-directed therapy: rethinking the target populations. Mediator-directed therapy in sepsis: rethinking the target populations. Toronto, Canada, 31 October-1 November 1998.
    Abraham E; Marshall JC
    Mol Med Today; 1999 Feb; 5(2):56-8. PubMed ID: 10200944
    [No Abstract]   [Full Text] [Related]  

  • 33. Sepsis and controlled clinical trials: the odyssey.
    Bone RC
    Crit Care Med; 1995 Jul; 23(7):1165-6. PubMed ID: 7600822
    [No Abstract]   [Full Text] [Related]  

  • 34. Thirty years of anti-mediator treatment in sepsis and septic shock--what have we learned?
    Neugebauer E; Rixen D; Raum M; Schäfer U
    Langenbecks Arch Surg; 1998 Mar; 383(1):26-34. PubMed ID: 9627168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide scavengers in the treatment of shock associated with systemic inflammatory response syndrome.
    De Angelo J
    Expert Opin Pharmacother; 1999 Nov; 1(1):19-29. PubMed ID: 11249560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bench to bedside: A role for erythropoietin in sepsis.
    Walden AP; Young JD; Sharples E
    Crit Care; 2010; 14(4):227. PubMed ID: 20727227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trial design for unmet clinical needs: a spotlight on sepsis.
    Vincent JL; Sakr Y
    Expert Rev Clin Pharmacol; 2019 Sep; 12(9):893-900. PubMed ID: 31295413
    [No Abstract]   [Full Text] [Related]  

  • 38. Practical implications of the availability of effective drugs to treat sepsis.
    Cohen J
    Curr Opin Crit Care; 2001 Oct; 7(5):345-6. PubMed ID: 11805531
    [No Abstract]   [Full Text] [Related]  

  • 39. Animal models of sepsis and shock: a review and lessons learned.
    Deitch EA
    Shock; 1998 Jan; 9(1):1-11. PubMed ID: 9466467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does blocking cytokines in sepsis work?
    Dinarello CA; Abraham E
    Am J Respir Crit Care Med; 2002 Nov; 166(9):1156-7. PubMed ID: 12403683
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.